Selected research
Industry Research
Glucosylceramidase Industry Research Report 2026
Market perspective
The global Glucosylceramidase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucosylceramidase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucosylceramidase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucosylceramidase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucosylceramidase include Takeda, The International Biotechnology Center (IBC) Generium, Protalix BioTherapeutics, Inc., Pharming Group N.V., JCR Pharmaceuticals Co., Ltd., greenovation Biotech GmbH, Bioorganic Research and Services S.A. and Amicus Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucosylceramidase market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucosylceramidase Market by Company
Takeda
The International Biotechnology Center (IBC) Generium
Protalix BioTherapeutics, Inc.
Pharming Group N.V.
JCR Pharmaceuticals Co., Ltd.
greenovation Biotech GmbH
Bioorganic Research and Services S.A.
Amicus Therapeutics, Inc.
Glucosylceramidase Segment by Type
Pcgin
NCGC-607
LTI-291
AVRRD-02
Others
Glucosylceramidase Segment by Application
Genetic Disorders
Parkinson's Disease
Gaucher Disease
Others
Glucosylceramidase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucosylceramidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucosylceramidase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucosylceramidase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucosylceramidase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucosylceramidase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucosylceramidase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pcgin
- NCGC-607
- LTI-291
- AVRRD-02
- Others
Applications
- Genetic Disorders
- Parkinson's Disease
- Gaucher Disease
- Others
Companies covered
- Takeda
- The International Biotechnology Center (IBC) Generium
- Protalix BioTherapeutics, Inc.
- Pharming Group N.V.
- JCR Pharmaceuticals Co., Ltd.
- greenovation Biotech GmbH
- Bioorganic Research and Services S.A.
- Amicus Therapeutics, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucosylceramidase Market Size (2021-2032)
- 2.2.2 Global Glucosylceramidase Sales (2021-2032)
- 2.2.3 Global Glucosylceramidase Market Average Price (2021-2032)
- 2.3 Glucosylceramidase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pcgin
- 2.3.3 NCGC-607
- 2.3.4 LTI-291
- 2.3.5 AVRRD-02
- 2.3.6 Others
- 2.4 Glucosylceramidase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Genetic Disorders
- 2.4.3 Parkinson's Disease
- 2.4.4 Gaucher Disease
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucosylceramidase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucosylceramidase Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Glucosylceramidase Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucosylceramidase Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucosylceramidase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucosylceramidase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucosylceramidase, Product Type & Application
- 3.8 Global Manufacturers of Glucosylceramidase, Established Date
- 3.9 Global Glucosylceramidase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Glucosylceramidase Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 The International Biotechnology Center (IBC) Generium
- 4.2.1 The International Biotechnology Center (IBC) Generium Company Information
- 4.2.2 The International Biotechnology Center (IBC) Generium Business Overview
- 4.2.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Product Portfolio
- 4.2.5 The International Biotechnology Center (IBC) Generium Recent Developments
- 4.3 Protalix BioTherapeutics, Inc.
- 4.3.1 Protalix BioTherapeutics, Inc. Company Information
- 4.3.2 Protalix BioTherapeutics, Inc. Business Overview
- 4.3.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Product Portfolio
- 4.3.5 Protalix BioTherapeutics, Inc. Recent Developments
- 4.4 Pharming Group N.V.
- 4.4.1 Pharming Group N.V. Company Information
- 4.4.2 Pharming Group N.V. Business Overview
- 4.4.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pharming Group N.V. Glucosylceramidase Product Portfolio
- 4.4.5 Pharming Group N.V. Recent Developments
- 4.5 JCR Pharmaceuticals Co., Ltd.
- 4.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
- 4.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
- 4.5.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product Portfolio
- 4.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
- 4.6 greenovation Biotech GmbH
- 4.6.1 greenovation Biotech GmbH Company Information
- 4.6.2 greenovation Biotech GmbH Business Overview
- 4.6.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 greenovation Biotech GmbH Glucosylceramidase Product Portfolio
- 4.6.5 greenovation Biotech GmbH Recent Developments
- 4.7 Bioorganic Research and Services S.A.
- 4.7.1 Bioorganic Research and Services S.A. Company Information
- 4.7.2 Bioorganic Research and Services S.A. Business Overview
- 4.7.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bioorganic Research and Services S.A. Glucosylceramidase Product Portfolio
- 4.7.5 Bioorganic Research and Services S.A. Recent Developments
- 4.8 Amicus Therapeutics, Inc.
- 4.8.1 Amicus Therapeutics, Inc. Company Information
- 4.8.2 Amicus Therapeutics, Inc. Business Overview
- 4.8.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Amicus Therapeutics, Inc. Glucosylceramidase Product Portfolio
- 4.8.5 Amicus Therapeutics, Inc. Recent Developments
5 Global Glucosylceramidase Market Scenario by Region
- 5.1 Global Glucosylceramidase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucosylceramidase Sales by Region: 2021-2032
- 5.2.1 Global Glucosylceramidase Sales by Region: 2021-2026
- 5.2.2 Global Glucosylceramidase Sales by Region: 2027-2032
- 5.3 Global Glucosylceramidase Revenue by Region: 2021-2032
- 5.3.1 Global Glucosylceramidase Revenue by Region: 2021-2026
- 5.3.2 Global Glucosylceramidase Revenue by Region: 2027-2032
- 5.4 North America Glucosylceramidase Market Facts & Figures by Country
- 5.4.1 North America Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucosylceramidase Sales by Country (2021-2032)
- 5.4.3 North America Glucosylceramidase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Glucosylceramidase Market Facts & Figures by Country
- 5.5.1 Europe Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucosylceramidase Sales by Country (2021-2032)
- 5.5.3 Europe Glucosylceramidase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Glucosylceramidase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucosylceramidase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucosylceramidase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucosylceramidase Market Facts & Figures by Country
- 5.7.1 South America Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucosylceramidase Sales by Country (2021-2032)
- 5.7.3 South America Glucosylceramidase Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Glucosylceramidase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucosylceramidase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucosylceramidase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucosylceramidase Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Glucosylceramidase Sales by Type (2021-2032)
- 6.1.1 Global Glucosylceramidase Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Glucosylceramidase Sales Market Share by Type (2021-2032)
- 6.2 Global Glucosylceramidase Revenue by Type (2021-2032)
- 6.2.1 Global Glucosylceramidase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucosylceramidase Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucosylceramidase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucosylceramidase Sales by Application (2021-2032)
- 7.1.1 Global Glucosylceramidase Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Glucosylceramidase Sales Market Share by Application (2021-2032)
- 7.2 Global Glucosylceramidase Revenue by Application (2021-2032)
- 7.2.1 Global Glucosylceramidase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucosylceramidase Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucosylceramidase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucosylceramidase Value Chain Analysis
- 8.1.1 Glucosylceramidase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucosylceramidase Production Mode & Process
- 8.2 Glucosylceramidase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucosylceramidase Distributors
- 8.2.3 Glucosylceramidase Customers
9 Global Glucosylceramidase Analyzing Market Dynamics
- 9.1 Glucosylceramidase Industry Trends
- 9.2 Glucosylceramidase Industry Drivers
- 9.3 Glucosylceramidase Industry Opportunities and Challenges
- 9.4 Glucosylceramidase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst